Avencia Sánchez-Mejías
Directeur Général chez Integra Therapeutics SL
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Marc Güell | M | - |
Integra Therapeutics SL
 Integra Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Integra Therapeutics SL is a Spanish Barcelona-based company founded in 2020 by Marc Güell and Avencia Sánchez-Mejías, with Avencia Sánchez-Mejías serving as the CEO since then. The company is focused on engineering the next-generation of gene writing tools to cure genetic and oncological diseases with high unmet medical need. Integra Therapeutics is committed to creating new gene writing tools that improve the scope, efficiency, and safety of advanced therapies. | - |
| Miles Gerson | M | - |
Integra Therapeutics SL
Integra Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Integra Therapeutics SL is a Spanish Barcelona-based company founded in 2020 by Marc Güell and Avencia Sánchez-Mejías, with Avencia Sánchez-Mejías serving as the CEO since then. The company is focused on engineering the next-generation of gene writing tools to cure genetic and oncological diseases with high unmet medical need. Integra Therapeutics is committed to creating new gene writing tools that improve the scope, efficiency, and safety of advanced therapies. | 3 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Espagne | 2 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Avencia Sánchez-Mejías
- Réseau Personnel
